THRASOS
Thrasos is a bio-therapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of severe organ failure, with a principle focus on kidney disease. The Company's lead therapeutic program, THR-184, is focused on the prevention and treatment of acute kidney injury (AKI). The Company also has a preclinical development program for treating chronic kidney disease (CKD).
THRASOS
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2002-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.thrasos.com
Total Employee:
51+
Status:
Closed
Contact:
514-940-2714
Email Addresses:
[email protected]
Total Funding:
56 M USD
Technology used in webpage:
SPF Amazon Amazon Ohio Region NameBright
Current Advisors List
Current Employees Featured
Founder
Investors List
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Series D - Thrasos
Lumira Ventures
Lumira Ventures investment in Series D - Thrasos
SR One
SR One investment in Series D - Thrasos
Pappas Ventures
Pappas Ventures investment in Series D - Thrasos
MP Healthcare Venture Management
MP Healthcare Venture Management investment in Series D - Thrasos
Advanced Technology Ventures
Advanced Technology Ventures investment in Series D - Thrasos
BDC Healthcare Venture
BDC Healthcare Venture investment in Series D - Thrasos
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Series C - Thrasos
Pappas Ventures
Pappas Ventures investment in Series C - Thrasos
Advanced Technology Ventures
Advanced Technology Ventures investment in Series C - Thrasos
